Webinar—Ultrasensitive Neuroimmune Biomarker Measurement for Translational Research and Therapeutic Development

Advancing neuroimmunology research and therapeutic development requires more than identifying biomarkers—it demands the ability to measure them accurately and translate those measurements into meaningful biological and clinical insights.

Join Quanterix and XTalks for an educational webinar exploring how ultrasensitive biomarker quantification is advancing neuroimmunology research across translational and clinical development programs. Learn how researchers are using highly sensitive digital immunoassay technologies to measure established and emerging neuroimmune biomarkers in cerebrospinal fluid (CSF), blood and other accessible matrices, supporting improved disease characterization, patient monitoring and therapeutic evaluation.

Attendees will gain insight into the application of key neuroimmune biomarkers, including:

• Neurofilament Light Chain (NfL)
• Glial Fibrillary Acidic Protein (GFAP)
• Soluble Triggering Receptor Expressed on Myeloid Cells 2 (sTREM2)
• YKL-40

These biomarkers are increasingly being utilized to assess neuroaxonal injury, astrocytic damage, microglial activation and neuroinflammatory processes throughout drug development and clinical research.